论文部分内容阅读
目的:探讨聚丙烯线前房植入术治疗新血管性青光眼的临床疗效。方法:对26例新生血管性青光眼患者在深层巩膜切除的基础上行聚丙烯线前房植入术。术后观察眼压、视力、滤过情况。结果:患者术前应用降眼压药物后,眼压平均29.50±10.05mmHg,术后一周眼压平均为14.53±6.75mmHg,差异有显著性(t=6.903,P<0.05)。术后1周视力恢复至术前水平,无前房出血、浅前房、晶体混浊等并发症。术后1～3个月随访功能滤过存在。结论:在深巩膜切除的基础上,行聚丙烯线前房植入术,眼压控制可靠,术后视力无明显变化,是治疗新生血管性限的有效方法。
Objective: To investigate the clinical effect of polypropylene line anterior chamber implantation in the treatment of neovascular glaucoma. Methods: 26 cases of neovascular glaucoma patients underwent deep sclerectomy on the basis of polypropylene line anterior chamber implantation. Postoperative intraocular pressure, visual acuity, filtration situation. Results: The intraocular pressure (IOP) was 29.50 ± 10.05mmHg preoperatively after IOP administration. The intraocular pressure was 14.53 ± 6.75mmHg one week after operation. The difference was significant (t = 6.903, P <0.05). Visual acuity returned to preoperative level at 1 week after surgery without any complications of anterior chamber hemorrhage, shallow anterior chamber and crystal opacity. 1 to 3 months after follow-up function filtration exists. Conclusion: On the basis of deep sclerectomy, polypropylene line anterior chamber implantation is a reliable method of intraocular pressure control and no significant change of postoperative visual acuity. It is an effective method for the treatment of neovascular limit.